AR024797A1 - CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINONAFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE - Google Patents

CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINONAFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE

Info

Publication number
AR024797A1
AR024797A1 ARP000103713A ARP000103713A AR024797A1 AR 024797 A1 AR024797 A1 AR 024797A1 AR P000103713 A ARP000103713 A AR P000103713A AR P000103713 A ARP000103713 A AR P000103713A AR 024797 A1 AR024797 A1 AR 024797A1
Authority
AR
Argentina
Prior art keywords
dimethylpropionamide
phenyl
crystalline form
dimethylaminonaftalen
sulphonylamine
Prior art date
Application number
ARP000103713A
Other languages
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR024797A1 publication Critical patent/AR024797A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forma cristalina III de la N-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida (DNSP)de formula (1).Crystalline form III of the N- (4- (5-dimethylaminonaphthalen-1-sulfonylamino) phenyl) -3-hydroxy-2,2-dimethylpropionamide (DNSP) of formula (1).

ARP000103713A 1999-07-21 2000-07-19 CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINONAFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE AR024797A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934295A DE19934295A1 (en) 1999-07-21 1999-07-21 New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections

Publications (1)

Publication Number Publication Date
AR024797A1 true AR024797A1 (en) 2002-10-23

Family

ID=7915608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103713A AR024797A1 (en) 1999-07-21 2000-07-19 CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINONAFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE

Country Status (8)

Country Link
AR (1) AR024797A1 (en)
AU (1) AU6562600A (en)
CO (1) CO5180571A1 (en)
DE (1) DE19934295A1 (en)
GT (1) GT200000114A (en)
PE (1) PE20010382A1 (en)
UY (1) UY26251A1 (en)
WO (1) WO2001007404A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780794B2 (en) 2000-01-20 2004-08-24 Honeywell International Inc. Methods of bonding physical vapor deposition target materials to backing plate materials
US6698647B1 (en) 2000-03-10 2004-03-02 Honeywell International Inc. Aluminum-comprising target/backing plate structures
US7371906B2 (en) * 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP2481540B1 (en) 2011-01-28 2017-11-01 Schelling Anlagenbau GmbH Device for sawing at least two plate or plate stack shaped workpieces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200000432A (en) * 1998-01-23 2001-12-17 Bayer Aktiengesellschaft Naphthyl and anilide-substituted sulfonamides

Also Published As

Publication number Publication date
AU6562600A (en) 2001-02-13
GT200000114A (en) 2002-01-01
PE20010382A1 (en) 2001-06-11
UY26251A1 (en) 2001-01-31
WO2001007404A1 (en) 2001-02-01
CO5180571A1 (en) 2002-07-30
DE19934295A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
RS49688B (en) New 3-aryl-2-hydroxypropionic acid derivative (i)
ATE270817T1 (en) FUNGICIDES
UY34152A (en) ? SUBSTITUTED OXAZOLIDINONES AND ITS USE ?.
ES2172864T3 (en) 2-FUNGICIDE METOXIBENZOPHENONES.
IT1319645B1 (en) CRYSTALLINE BASE OF CITALOPRAM.
PT1413582E (en) PYRROLOBENZODIAZEPINAS DIMERICAS
SE0004245D0 (en) Novel compounds and their use
ATE244699T1 (en) SUBSTITUTED ANILINE COMPOUNDS
EE200200275A (en) 2,4-Diaminopyrimidine compounds used as immunosuppressants
EA200000826A1 (en) HALIDATED DERIVATIVES OF AMIDINOMOMINO ACIDS APPLICABLE AS NO-SYNTHASE INHIBITORS
SE0103710D0 (en) Compounds
DK1216284T3 (en) R 22 replacement coolant
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
BR0007922A (en) Calcilic compounds
MY128164A (en) Compounds
BG104575A (en) Matrix metalloprotease inhibitors
DE60025958D1 (en) 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE
DK1377574T3 (en) 6-phenylbenzonaphthyridines
DK1204659T3 (en) Serotonergic benzofurans
NO20030868D0 (en) N- (3,5-dichloro-2-methoxyphenyl) -4-methoxy-3-piperazin-1-yl-benzenesulfonamide
AR024797A1 (en) CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINONAFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE
DE59803066D1 (en) SUBSTITUTED BENZYLOXYIMINO COMPOUNDS
RS52014B (en) Novel benzoylguanidine salt
NO20024679D0 (en) Crystalline Pharmaceuticals
PT1104419E (en) AZABICYCLOHEPTAN DERIVATIVES SUBSTITUTED IN NITROGEN ITS PREPARATION AND UTILIZATION